Researchers Create Blood Test to Predict Heart Attack

Heart disease is a terrifying killer, responsible for the deaths of more men and women annually than all forms of cancer combined. It can occur without warning, and even if a patient survives a heart attack it only increases the chances of it happening again. Scientists at the Scripps Research Institute in Canada have found a way to determine one’s chances of suffering a heart attack from nothing more than a simple blood test. Before, there was no approved blood test that could be used to accurately predict an individual’s risk of heart attack, but this new discovery has, so far, been successful in differentiating recovering patients of heart attacks and those who have never suffered a heart attack.

In simple terms, the test performs a fluid biopsy to identify the presence of endothelial cells in the bloodstream. Endothelial cells originate from the walls of arteries, and their presence in the bloodstream has been associated with ongoing heart attacks. Scientists believe that these cells enter the bloodstream when plaque builds up in the arteries, causing the walls of the arteries to rupture. The inflammation that follows increases the chance of blood clots, or blocks in the flow of the bloodstream. The procedure is referred to as the High-Definition Circulating Endothelial Cell (HD-CEC) assay, and scientists were able to identify the endothelial cells in patients who had already suffered heart attacks. When compared to patients who had never suffered a heart attack, the scientists were able to easily distinguish the patients of both groups.

Patients who had suffered a heart attack had higher concentrations of endothelial cells circulating in their blood than those who had not. The HD-CEC test even proved to be more accurate than the current standard in finding tumor cells, the CellSearch test. In theory, those who have not suffered a heart attack, but are at a higher risk will have higher levels of endothelial cells in their bloodstream, and scientists believe that the test is ready for regular patient testing.

To learn more about advances in cardiac monitoring and technology, contact us or visit today.

Jodi is a seasoned Human Resources professional who thrives on change and transformation. She fell in love with Human Resources when she attended Penn State University for graduate school in Public Administration with a curriculum that emphasized Human Resources. After earning her Master’s degree she began her career in the manufacturing industry in Talent Acquisition and was eventually assigned the overall HR Management responsibility of three divisions which included collective bargaining. Ultimately, she made her way to transitioning a new division of a Fortune 100 company under the corporate model as well as developing and executing Human Resources policies and procedures across a broad range of functional disciplines. At the next juncture of her career, she was tapped on the shoulder by former Executives that she previously worked with to join in on an exciting start-up. Today, Jodi is the Vice President of Talent Relations and Development for Medicomp Inc dba ReactDx and is responsible for managing the strategic Human Resources function which includes mergers and acquisitions for this rapidly expanding company.

Jodi and her husband enjoy landscaping, finding new restaurants and traveling whenever life gives them the opportunity.

    *This form is intended for sales inquiries/information only. Do not include any patient health information (PHI) with your submission.

    On: all lights. Off: no light. Monitoring - Good: green light. Symptom press: green light, sound. Check Pendant: blue light. Check Battery: red light, sound.
    Do: wear always, fully insert in cradle, turn off to charge, dry, key near handset, return promptly. Don't: discard pendant, submerge, move patch